Mucosal inflammation in spondylarthritides: past, present, and future. - Wikidata - wikimedia - TriplyDB

Mucosal inflammation in spondylarthritides: past, present, and future.

Mucosal inflammation in spondylarthritides: past, present, and future.

http://www.wikidata.org/entity/Q39730329

about

Etoricoxib and the treatment of ankylosing spondylitis.Genetics, environment, and gene-environment interactions in the development of systemic rheumatic diseases Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.Enteropathic spondyloarthritis: from diagnosis to treatment.Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study.Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use.The microbiome and psoriatic arthritis.Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology.Critical role of environmental factors in the pathogenesis of psoriasis.Elevated serum levels of calprotectin (myeloid-related protein 8/14) in patients with ankylosing spondylitis and its association with disease activity and quality of life.Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial.Cytokines and integrins related to inflammation of joint and gut in patients with spondyloarthritis and inflammatory bowel disease.

P2860

Q34466689-36FDF501-CDB4-4E20-A3CB-5475E4145AAD Q34604608-744DD45D-E44A-4E1D-945E-8B01A17BBBEB Q34791372-0CE926C4-31FD-4F0C-9999-9DCF048AEB9B Q36830824-25D35DA9-7D3E-436C-BEF4-459B247D57B0 Q36907655-964C2A82-7A69-4D3C-BDFC-29354B8D59ED Q37618733-565A915E-A6CA-4FF9-9352-6784FC1D2764 Q38182899-89E19483-947D-4767-B195-D1D086CBEEFB Q38634692-52546F93-5900-4B1E-BCC7-5601032AE195 Q38871762-5449D006-E6ED-4FD6-804B-FE497186F081 Q48073454-4BC4BDBC-4D35-475F-9AB0-5981FFCD1A9B Q53828369-9659BB1B-C6B1-4CA6-ACA2-114C7D2A310A Q55027377-DDEEBD5C-9ADC-4FD5-9C37-46BD90FC7452

P2860

Mucosal inflammation in spondylarthritides: past, present, and future.

http://www.wikidata.org/entity/Q39730329

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Mucosal inflammation in spondylarthritides: past, present, and future.

@en

Mucosal inflammation in spondylarthritides: past, present, and future.

@nl

type

label

Mucosal inflammation in spondylarthritides: past, present, and future.

@en

Mucosal inflammation in spondylarthritides: past, present, and future.

@nl

prefLabel

Mucosal inflammation in spondylarthritides: past, present, and future.

@en

Mucosal inflammation in spondylarthritides: past, present, and future.

@nl

P1433

Q39730329-1605921D-D2B0-4950-AF8C-13232C153A4F

P1476

Q39730329-9FAEEAE6-03FE-46AC-B9DE-01FC76F0E445

P2093

Q39730329-239D67CB-0008-4855-977F-6E282D5F922D

Q39730329-64D028D4-6DAC-41C8-91CF-7F984C3E0F80

Q39730329-72C8FC99-A8E4-447B-9661-86CF73CFD105

Q39730329-9E13951F-E1A6-4178-BD2D-23D56391461C

P2860

Q39730329-0A48AAE1-0A00-4FEB-97F7-8E61C61CE565

Q39730329-12EC3F4D-EDA5-4865-AAE4-E6CB538CFA1B

Q39730329-167B8EC1-5DAC-4410-BC02-85A145F9C553

Q39730329-1FE6F157-F596-46F2-BCBF-D3EFB62AE40E

Q39730329-266A177C-E108-43C0-A1DD-52B1913D7EFA

Q39730329-2D349D7B-690A-4327-98CB-D986A372CBFA

Q39730329-34185E45-3680-457B-8AE4-AEB6F64DDD6B

Q39730329-39D869B7-6579-4B33-83F9-3B33F44680A0

Q39730329-3BD38DCC-8D14-488B-BEC3-4F7F33AD75B9

Q39730329-3DD91457-F5F6-478F-B0FC-12714D1BF1BF

P2888

Q39730329-DDAFEC9A-7BD0-429F-AF5F-0A6651D002FE

P304

Q39730329-D423FE04-CA4C-4CB2-A5C9-5C0D1340F6B1

P31

Q39730329-0DC002A4-8F9B-40B5-9792-938023C3458F

P356

Q39730329-F5890ED5-3060-4D37-A0AA-9CD7161E014A

P433

Q39730329-220C5CD0-A521-4375-9E16-ABD70E415A87

P478

Q39730329-F8E2E7BB-8130-4BB0-9B02-63B7952464EA

P577

Q39730329-FEEF6B17-3F94-495A-8DA5-BB2FF081D2E6

P698

Q39730329-BC1ADBC3-97B5-429E-A07C-F029036C4472

P356

S11926-011-0198-2

P1433

Current Rheumatology Reports

P1476

Mucosal inflammation in spondylarthritides: past, present, and future.

@en

P2093

Dirk Elewaut

http://www.w3.org/2001/XMLSchema#string

Filip Van den Bosch

http://www.w3.org/2001/XMLSchema#string

Herman Mielants

http://www.w3.org/2001/XMLSchema#string

Liesbet Van Praet

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

Anti-interleukin-12 antibody for active Crohn's disease

Inflammatory bowel disease

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group.

Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.

Histopathology of intestinal inflammation related to reactive arthritis.

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

P2888

s11926-011-0198-2

P304

409-415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11926-011-0198-2

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21744132

http://www.w3.org/2001/XMLSchema#string